Sherrington Robin

Insider Reports History

Entity
Individual
Location
C/O Xenon Pharmaceuticals Inc., 200 3650 Gilmore Way, Burnaby, British Columbia, Canada
Signature
/s/ Nathaniel Adams, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sherrington Robin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xenon Pharmaceuticals Inc. EVP, Strategy & Innovation Common Shares 8.4K $389K $46.30 Mar 7, 2024 Direct
Xenon Pharmaceuticals Inc. EVP, Strategy & Innovation Stock Option (Right to Buy) 65K Mar 11, 2024 Direct

Insider Reports Filed by Sherrington Robin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XENE Xenon Pharmaceuticals Inc. Mar 11, 2024 1 $0 4 Mar 12, 2024 EVP, Strategy & Innovation
XENE Xenon Pharmaceuticals Inc. Mar 7, 2024 8 -$314K 4 Mar 8, 2024 EVP, Strategy & Innovation
XENE Xenon Pharmaceuticals Inc. Dec 29, 2023 1 $0 4 Jan 2, 2024 EVP, Strategy & Innovation
XENE Xenon Pharmaceuticals Inc. Mar 10, 2023 1 $0 4 Mar 14, 2023 EVP, Strategy & Innovation
XENE Xenon Pharmaceuticals Inc. Aug 31, 2022 11 -$2.49M 4 Sep 2, 2022 EVP, Strategy & Innovation
XENE Xenon Pharmaceuticals Inc. Mar 10, 2022 1 $0 4 Mar 14, 2022 EVP, Strategy & Innovation
XENE Xenon Pharmaceuticals Inc. Mar 4, 2022 9 -$657K 4 Mar 8, 2022 EVP, Strategy & Innovation
XENE Xenon Pharmaceuticals Inc. May 28, 2021 8 -$95.9K 4 Jun 1, 2021 EVP, Strategy & Innovation